China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

 Table of Contents


China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021
1 Drugs for Treatment of Prostate Cancer Overview and Each Type
1.1 Product Overview of Prostate Cancer
1.1.1 Definition and Product Scope of Drugs for Prostate Cancer
1.1.2 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.3 Russia Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.4 Brazil Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.5 Japan Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List and of Each Type 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Triptorelin and Specification
1.2.5 Leuprorelin and Specification
1.2.6 Flutamide Tablets and Specification
1.2.7 Goserelin and Specification
1.2.8 Bicalutamide Tablets and Specification
1.2.9 Bicalutamide Capsules and Specification
1.2.10 Estramustine Phosphate Capsules and Specification
1.2.11 Mitoxantrone and Specification
1.2.12 Zytiga and Specification
1.2.13 Xtandi and Specification
1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016
1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers
1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers
1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers
1.3.4 Price List (Interviewed) of Goserelin by Manufacturers
1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers
1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers
1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers
1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers
1.3.9 Price List (Interviewed) of Zytiga by Manufacturers
1.3.10 Price List (Interviewed) of Xtandi by Manufacturers
2 Competition Analysis by Manufacturers in Global and China
2.1 Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.3 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.4 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.5 Russia Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.6 Russia Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.7 Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.8 Brazil Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.9 Brazil Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.10 Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.11 Japan Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.12 Japan Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.13 Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
3 Sales and Revenue Segments of Each Type 2010 to 2015
3.1 China Sales and Revenue Segments of Each Type 2010 to 2015
3.1.1 China Sales and Market Share of Each Type 2010 to 2015
3.1.2 China Sales Growth Rate of Each Type 2015 to 2016
3.1.3 China Revenue and Market Share of Each Type 2015 to 2016
3.1.4 China Revenue and Market Share of Each Type 2015 to 2016
3.2 Russia Sales and Revenue Segments of Each Type 2015 to 2016
3.2.1 Russia Sales and Market Share of Each Type 2015 to 2016
3.2.2 Russia Sales Growth Rate of Each Type 2015 to 2016
3.2.3 Russia Revenue and Market Share of Each Type 2015 to 2016
3.2.4 Russia Revenue and Market Share of Each Type 2015 to 2016
3.3 Brazil Sales and Revenue Segments of Each Type 2015 to 2016
3.3.1 Brazil Sales and Market Share of Each Type 2015 to 2016
3.3.2 Brazil Sales Growth Rate of Each Type 2015 to 2016
3.3.3 Brazil Revenue and Market Share of Each Type 2015 to 2016
3.3.4 Brazil Revenue and Market Share of Each Type 2015 to 2016
3.4 Japan Sales and Revenue Segments of Each Type 2015 to 2016
3.3.1 Japan Sales and Market Share of Each Type 2015 to 2016
3.3.2 Japan Sales Growth Rate of Each Type 2015 to 2016
3.3.3 Japan Revenue and Market Share of Each Type 2015 to 2016
3.3.4 Japan Revenue and Market Share of Each Type 2015 to 2016
4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
5 Raw Materials and Applications
5.1 Key Raw Materials and Price Analysis for Triptorelin
5.1.1 Key Raw Materials for Triptorelin
5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Leuprorelin
5.2.1 Key Raw Materials for Leuprorelin
5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Flutamide Tablets
5.3.1 Key Raw Materials for Flutamide Tablets
5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Goserelin
5.4.1 Key Raw Materials for Goserelin
5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets
5.5.1 Key Raw Materials for Bicalutamide Tablets
5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules
5.6.1 Key Raw Materials for Bicalutamide Capsules
5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules
5.7.1 Key Raw Materials for Estramustine Phosphate Capsules
5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Mitoxantrone
5.8.1 Key Raw Materials for Mitoxantrone
5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Zytiga
5.9.1 Key Raw Materials for Zytiga
5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Xtandi
5.10.1 Key Raw Materials for Xtandi
5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021
5.11 Applications of Triptorelin
5.12 Applications of Leuprorelin
5.13 Applications of Flutamide Tablets
5.14 Applications of Goserelin
5.15 Applications of Bicalutamide Tablets
5.16 Applications of Bicalutamide Capsules
5.17 Applications of Estramustine Phosphate Capsules
5.18 Applications of Mitoxantrone
5.19 Applications of Zytiga
5.20 Applications of Xtandi
6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer
6.1 IPSEN
6.1.1 IPSEN Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.1.4 Interviewee, Name and Contact
6.2 Ferring Pharmaceuticals
6.2.1 Company Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.4 Interviewee, Name and Contact
6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Company Basic Information
6.3.2 Triptorelin (Specification and Price)
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.4 Interviewee, Name and Contact
6.4 GeneScience Pharmaceuticals
6.4.1 Company Basic Information
6.4.2 Triptorelin (Specification and Price)
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.4 Interviewee, Name and Contact
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Basic Information
6.5.2 Leuprorelin (Specification and Price)
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.4 Interviewee, Name and Contact
6.6 Beijing Biote Pharmaceutical
6.6.1 Company Basic Information
6.6.2 Leuprorelin (Specification and Price)
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.4 Interviewee, Name and Contact
6.7 Livzon Pharmaceutical Group
6.7.1 Company Basic Information
6.7.2 Leuprorelin (Specification and Price)
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.4 Interviewee, Name and Contact
6.8 Schering-Plough Canada
6.8.1 Company Basic Information
6.8.2 Flutamide Tablets (Specification and Price)
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.4 Interviewee, Name and Contact
6. 9 JiangSu TASLY DI YI Pharmaceutical
6.9.1 Company Basic Information
6.9.2 Flutamide Tablets (Specification and Price)
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.4 Interviewee, Name and Contact
6.10 Shanghai Fudan Fuhua Pharmaceutical
6.10.1 Company Basic Information
6.10.2 Flutamide Tablets (Specification and Price)
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.4 Interviewee, Name and Contact
6.11 S.C.SINDAN-PHARMA S.R.L.
6.11.1 Company Basic Information
6.11.2 Flutamide Tablets (Specification and Price)
6.11.3 Sales Value, Gross Margin 2011-2016
6.11.4 Interviewee, Name and Contact
6.12 AstraZeneca
6.12.1 Company Basic Information
6.12.2 Goserelin (Specification and Price)
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.4 Interviewee, Name and Contact
6.13 Corden Pharma GmbH
6.13.1 Company Basic Information
6.13.2 Bicalutamide Tablets (Specification and Price)
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.4 Interviewee, Name and Contact
6.14 Shanghai Zhaohui Pharmaceutical
6.14.1 Company Basic Information
6.14.2 Bicalutamide Tablets (Specification and Price)
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.4 Interviewee, Name and Contact
6.15 HISUN Pharmaceutical
6.15.1 Company Basic Information
6.15.2 Bicalutamide Tablets (Specification and Price)
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.4 Interviewee, Name and Contact
6.16 Shanxi Zhendong Pharmaceutical
6.16.1 Company Basic Information
6.16.2 Bicalutamide Capsules (Specification and Price)
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.4 Interviewee, Name and Contact
6.17 Pfizer
6.17.1 Company Basic Information
6.17.2 Estramustine Phosphate Capsules (Specification and Price)
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.4 Interviewee, Name and Contact
6.18 Sichuan sunnyhope pharmaceutical
6.18.1 Company Basic Information
6.18.2 Mitoxantrone (Specification and Price)
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.4 Interviewee, Name and Contact
6.19 Luoxin Group
6.19.1 Company Basic Information
6.19.2 Mitoxantrone (Specification and Price)
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.4 Interviewee, Name and Contact
6.20 Jiangsu Aosaikang Pharmaceutical
6.20.1 Company Basic Information
6.20.2 Mitoxantrone (Specification and Price)
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.4 Interviewee, Name and Contact
6.21 JIANG SU HENG RUI MEDICINE
6.21.1 Company Basic Information
6.21.2 Mitoxantrone (Specification and Price)
6.21.3 Sales Value, Gross Margin 2011-2016
6.21.4 Interviewee, Name and Contact
6.22 Johnson
6.22.1 Company Basic Information
6.22.2 Zytiga (Specification and Price)
6.22.3 Sales Value, Gross Margin 2011-2016
6.22.4 Interviewee, Name and Contact
6.23 Astellas
6.23.1 Company Basic Information
6.23.2 Xtandi (Specification and Price)
6.23.3 Sales Value, Gross Margin 2011-2016
6.23.4 Interviewee, Name and Contact
7 Technology Development Trend
7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer
7.2 Analysis of Manufacturing Process
7.3 Development Trend
8 Research Findings and Conclusion

List of Tables and Figures


Figure Picture of Drugs for Prostate Cancer	17
Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-2021	17
Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-2021	17
Figure Russia Market Size (Value) of Drugs for Prostate Cancer 2016-2021	17
Figure Russia Market Size (Volume) of Drugs for Prostate Cancer 2016-2021	18
Figure Brazil Market Size (Value) of Drugs for Prostate Cancer 2016-2021	18
Figure Brazil Market Size (Volume) of Drugs for Prostate Cancer 2016-2021	18
Figure Japan Market Size (Value) of Drugs for Prostate Cancer 2016-2021	18
Figure Japan Market Size (Volume) of Drugs for Prostate Cancer 2016-2021	18
Table Product Type of Key Manufacturers	18
Table Price List and Forecast of Each Type	19
Table Market Share of Each Type	19
Figure Growth Rate of Each Type 2014 to 2015	20
Figure Picture of Triptorelin	20
Table Specification of Triptorelin	20
Figure Picture of Leuprorelin	20
Table Specification of Leuprorelin	20
Figure Picture of Flutamide Tablets	21
Table Specification of Flutamide Tablets	21
Figure Picture of Goserelin	21
Table Specification of Goserelin	21
Figure Picture of Bicalutamide Tablets	21
Table Specification of Bicalutamide Tablets	21
Figure Picture of Type Bicalutamide Capsules	21
Table Specification of Type Bicalutamide Capsules	21
Figure Picture of Estramustine Phosphate Capsules	22
Table Specification of Estramustine Phosphate Capsules	22
Figure Picture of Mitoxantrone	22
Table Specification of Mitoxantrone	22
Figure Picture of Zytiga	22
Table Specification of Zytiga	22
Figure Picture of Xtandi	22
Table Specification of Xtandi	23
Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 2016	23
Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 2016	23
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016	24
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016	24
Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 2016	25
Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 2016	25
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016	26
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016	26
Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 2016	27
Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 2016	27
Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 2016	28
Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 2016	28
Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015	29
Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015	29
Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015	30
Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015	30
Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016	31
Table Russia Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015	32
Table Russia Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015	32
Table Russia Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015	33
Table Russia Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015	33
Table Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016	34
Table Brazil Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015	34
Table Brazil Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015	35
Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015	35
Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015	36
Table Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016	36
Table Japan Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015	37
Table Japan Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015	37
Table Japan Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015	38
Table Japan Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015	39
Table Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016	39
Table China Sales of Each Type 2010 to 2015	40
Table China Sales Market Share of Each Type 2010 to 2015	40
Table China Sales Growth Rate of Each Type 2015 to 2016	40
Table China Revenue of Each Type 2015 to 2016	41
Table China Revenue Market Share of Each Type 2015 to 2016	41
Table China Revenue of Each Type 2015 to 2016	41
Table China Revenue Market Share of Each Type 2015 to 2016	42
Table Global Sales of Each Type 2015 to 2016	42
Table Russia Sales Market Share of Each Type 2015 to 2016	42
Table Global Sales Growth Rate of Each Type 2015 to 2016	42
Table Global Revenue of Each Type 2015 to 2016	43
Table Russia Revenue Market Share of Each Type 2015 to 2016	43
Table Russia Revenue of Each Type 2015 to 2016	43
Table Russia Revenue Market Share of Each Type 2015 to 2016	44
Table Brazil Sales of Each Type 2015 to 2016	44
Table Brazil Sales Market Share of Each Type 2015 to 2016	44
Table Brazil Sales Growth Rate of Each Type 2015 to 2016	45
Table Brazil Revenue of Each Type 2015 to 2016	45
Table Brazil Revenue Market Share of Each Type 2015 to 2016	45
Table Brazil Revenue of Each Type 2015 to 2016	45
Table Brazil Revenue Market Share of Each Type 2015 to 2016	46
Table Japan Sales of Each Type 2015 to 2016	46
Table Japan Sales Market Share of Each Type 2015 to 2016	46
Table Japan Sales Growth Rate of Each Type 2015 to 2016	47
Table Japan Revenue of Each Type 2015 to 2016	47
Table Japan Revenue Market Share of Each Type 2015 to 2016	47
Table Japan Revenue of Each Type 2015 to 2016	47
Table Japan Revenue Market Share of Each Type 2015 to 2016	48
Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021	49
Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021	50
Table Key Raw Materials for Triptorelin	51
Table Price Forecast of Key Raw Materials for Triptorelin	51
Table Key Raw Materials for Leuprorelin	52
Table Price Forecast of Key Raw Materials for Leuprorelin	52
Table Key Raw Materials for Flutamide Tablets	52
Table Price Forecast of Key Raw Materials for Flutamide Tablets	53
Table Key Raw Materials for Goserelin	53
Table Price Forecast of Key Raw Materials for Goserelin	53
Table Key Raw Materials for Bicalutamide Tablets	54
Table Price Forecast of Key Raw Materials for Bicalutamide Tablets	54
Table Key Raw Materials for Bicalutamide Capsules	55
Table Price Forecast of Key Raw Materials for Bicalutamide Capsules	55
Table Key Raw Materials for Estramustine Phosphate Capsules	55
Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules	56
Table Key Raw Materials for Mitoxantrone	56
Table Price Forecast of Key Raw Materials for Mitoxantrone	57
Table Key Raw Materials for Zytiga	57
Table Price Forecast of Key Raw Materials for Zytiga	57
Table Key Raw Materials for Xtandi	58
Table Price Forecast of Key Raw Materials for Zytiga	58
Table Applications of Triptorelin	58
Table Applications of Leuprorelin	59
Table Applications of Flutamide Tablets	59
Table Applications of Goserelin	59
Table Applications of Bicalutamide Tablets	59
Table Applications of Bicalutamide Capsules	60
Table Applications of Estramustine Phosphate Capsules	60
Table Applications of Mitoxantrone	60
Table Applications of Zytiga	61
Table Applications of Xtandi	61
Table IPSEN Basic Information List	62
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of IPSEN	62
Table Sales Value, Gross Margin and Growth rate of IPSEN in China	62
Figure Product Sales Value, Growth rate of IPSEN in China	63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Russia	63
Figure Product Sales Value, Growth rate of IPSEN in Russia	63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Brazil	63
Figure Product Sales Value, Growth rate of IPSEN in Brazil	63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Japan	63
Figure Product Sales Value, Growth rate of IPSEN in Japan	64
Table Ferring Pharmaceuticals Basic Information List	64
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Ferring Pharmaceuticals	64
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in China	65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in China	65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Russia	65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Russia	65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Brazil	65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Brazil	65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Japan	66
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Japan	66
Table Chengdu Tiantaishan pharmaceutical Basic Information List	66
Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical in China	67
Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical in China	67
Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical in China	67
Table GeneScience Pharmaceuticals Basic Information List	67
Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals in China	68
Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals in China	68
Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals in China	68
Table Takeda Pharmaceutical Company Limited Basic Information List	69
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Takeda Pharmaceutical Company Limited	69
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in China	69
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in China	70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Russia	70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Russia	70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Brazil	70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Brazil	70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Japan	70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Japan	71
Table Beijing Biote Pharmaceutical Basic Information List	71
Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical in China	71
Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical in China	72
Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical in China	72
Table Livzon Pharmaceutical Group Basic Information List	72
Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group in China	73
Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group in China	73
Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group in China	73
Table Schering-Plough Canada Basic Information List	73
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Schering-Plough Canada	74
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in China	74
Figure Product Sales Value, Growth rate of Schering-Plough Canada in China	74
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Russia	74
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Russia	75
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Brazil	75
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Brazil	75
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Japan	75
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Japan	75
Table JiangSu TASLY DI YI Pharmaceutical Basic Information List	76
Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical in China	76
Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical in China	76
Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical in China	77
Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List	77
Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical in China	77
Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China	78
Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China	78
Table S.C.SINDAN-PHARMA S.R.L. Basic Information List	78
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of S.C.SINDAN-PHARMA S.R.L.	79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in China	79
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in China	79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia	79
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia	79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil	80
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil	80
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan	80
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan	80
Table AstraZeneca Basic Information List	80
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer	81
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in China	81
Figure Product Sales Value, Growth rate of AstraZeneca in China	81
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Russia	81
Figure Product Sales Value, Growth rate of AstraZeneca in Russia	82
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Brazil	82
Figure Product Sales Value, Growth rate of AstraZeneca in Brazil	82
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Japan	82
Figure Product Sales Value, Growth rate of AstraZeneca in Japan	82
Table Corden Pharma GmbH Basic Information List	83
Table Specification, Price, Sales Value(China, Russia, Brazil and Japan)and Market Share of Corden Pharma GmbH	83
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in China	83
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in China	84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Russia	84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Russia	84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Brazil	84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Brazil	84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Japan	84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Japan	85
Table Shanghai Zhaohui Pharmaceutical Basic Information List	85
Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical in China	85
Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical in China	86
Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical in China	86
Table HISUN Pharmaceutical Basic Information List	86
Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical in China	87
Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical in China	87
Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical in China	87
Table Shanxi Zhendong Pharmaceutical Basic Information List	87
Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical in China	88
Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical in China	88
Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical in China	88
Table Pfizer Basic Information List	89
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer	89
Table Sales Value, Gross Margin and Growth rate of Pfizer in China	89
Figure Product Sales Value, Growth rate of Pfizer in China	90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Russia	90
Figure Product Sales Value, Growth rate of Pfizer in Russia	90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Brazil	90
Figure Product Sales Value, Growth rate of Pfizer in Brazil	90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Japan	90
Figure Product Sales Value, Growth rate of Pfizer in Japan	90
Table Sichuan sunnyhope pharmaceutical Basic Information List	91
Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical in China	91
Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical in China	91
Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical in China	92
Table Luoxin Group Basic Information List	92
Table Specification, Price, Sales Value and Market Share of Luoxin Group in China	92
Table Sales Value, Gross Margin and Growth rate of Luoxin Group in China	93
Figure Product Sales Value, Growth rate of Luoxin Group in China	93
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List	93
Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical in China	94
Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical in China	94
Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical	94
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List	94
Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE in China	95
Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE China	95
Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE in China	95
Table Johnson Basic Information List	96
Table Specification, Price, Sales Value and Market Share of Johnson in Japan	96
Table Sales Value, Gross Margin and Growth rate of Johnson in Japan	96
Figure Product Sales Value, Growth rate of Johnson in Japan	96
Table Sales Value, Gross Margin and Growth rate of Johnson in Russia	97
Figure Product Sales Value, Growth rate of Johnson in Russia	97
Table Astellas Basic Information List	97
Table Specification, Price, Sales Value and Market Share of Astellas in Japan	97
Table Sales Value, Gross Margin and Growth rate of Astellas in Japan	98
Figure Product Sales Value, Growth rate of Astellas in Japan	98

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy